Table of Content

1 Measles Vaccine Market Overview
1.1 Product Overview and Scope of Measles Vaccine
1.2 Measles Vaccine Segment by Type
1.2.1 Global Measles Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.2.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
1.3 Measles Vaccine Segment by Application
1.3.1 Global Measles Vaccine Market Value by Application: (2024-2034)
1.3.2 Children
1.3.3 Adults
1.4 Global Measles Vaccine Market Size Estimates and Forecasts
1.4.1 Global Measles Vaccine Revenue 2018-2034
1.4.2 Global Measles Vaccine Sales 2018-2034
1.4.3 Global Measles Vaccine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Measles Vaccine Market Competition by Manufacturers
2.1 Global Measles Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Measles Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Measles Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Measles Vaccine Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Measles Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Measles Vaccine, Product Type & Application
2.7 Measles Vaccine Market Competitive Situation and Trends
2.7.1 Measles Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Measles Vaccine Players Market Share by Revenue
2.7.3 Global Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Measles Vaccine Retrospective Market Scenario by Region
3.1 Global Measles Vaccine Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Measles Vaccine Global Measles Vaccine Sales by Region: 2018-2034
3.2.1 Global Measles Vaccine Sales by Region: 2018-2023
3.2.2 Global Measles Vaccine Sales by Region: 2024-2034
3.3 Global Measles Vaccine Global Measles Vaccine Revenue by Region: 2018-2034
3.3.1 Global Measles Vaccine Revenue by Region: 2018-2023
3.3.2 Global Measles Vaccine Revenue by Region: 2024-2034
3.4 North America Measles Vaccine Market Facts & Figures by Country
3.4.1 North America Measles Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Measles Vaccine Sales by Country (2018-2034)
3.4.3 North America Measles Vaccine Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Measles Vaccine Market Facts & Figures by Country
3.5.1 Europe Measles Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Measles Vaccine Sales by Country (2018-2034)
3.5.3 Europe Measles Vaccine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Measles Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Measles Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Measles Vaccine Sales by Country (2018-2034)
3.6.3 Asia Pacific Measles Vaccine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Measles Vaccine Market Facts & Figures by Country
3.7.1 Latin America Measles Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Measles Vaccine Sales by Country (2018-2034)
3.7.3 Latin America Measles Vaccine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Measles Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Measles Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Measles Vaccine Sales by Country (2018-2034)
3.8.3 Middle East and Africa Measles Vaccine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Measles Vaccine Sales by Type (2018-2034)
4.1.1 Global Measles Vaccine Sales by Type (2018-2023)
4.1.2 Global Measles Vaccine Sales by Type (2024-2034)
4.1.3 Global Measles Vaccine Sales Market Share by Type (2018-2034)
4.2 Global Measles Vaccine Revenue by Type (2018-2034)
4.2.1 Global Measles Vaccine Revenue by Type (2018-2023)
4.2.2 Global Measles Vaccine Revenue by Type (2024-2034)
4.2.3 Global Measles Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Measles Vaccine Price by Type (2018-2034)
5 Segment by Application
5.1 Global Measles Vaccine Sales by Application (2018-2034)
5.1.1 Global Measles Vaccine Sales by Application (2018-2023)
5.1.2 Global Measles Vaccine Sales by Application (2024-2034)
5.1.3 Global Measles Vaccine Sales Market Share by Application (2018-2034)
5.2 Global Measles Vaccine Revenue by Application (2018-2034)
5.2.1 Global Measles Vaccine Revenue by Application (2018-2023)
5.2.2 Global Measles Vaccine Revenue by Application (2024-2034)
5.2.3 Global Measles Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Measles Vaccine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GSK Measles Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Corporation Information
6.2.2 Sanofi-Pasteur Description and Business Overview
6.2.3 Sanofi-Pasteur Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sanofi-Pasteur Measles Vaccine Product Portfolio
6.2.5 Sanofi-Pasteur Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Merck Measles Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis Measles Vaccine Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Pfizer Measles Vaccine Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Serum Institute of India Measles Vaccine Product Portfolio
6.6.5 Serum Institute of India Recent Developments/Updates
6.7 China National Biotech Group
6.6.1 China National Biotech Group Corporation Information
6.6.2 China National Biotech Group Description and Business Overview
6.6.3 China National Biotech Group Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 China National Biotech Group Measles Vaccine Product Portfolio
6.7.5 China National Biotech Group Recent Developments/Updates
6.8 Bavarian Nordic
6.8.1 Bavarian Nordic Corporation Information
6.8.2 Bavarian Nordic Description and Business Overview
6.8.3 Bavarian Nordic Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bavarian Nordic Measles Vaccine Product Portfolio
6.8.5 Bavarian Nordic Recent Developments/Updates
6.9 Emergent Biosolutions
6.9.1 Emergent Biosolutions Corporation Information
6.9.2 Emergent Biosolutions Description and Business Overview
6.9.3 Emergent Biosolutions Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Emergent Biosolutions Measles Vaccine Product Portfolio
6.9.5 Emergent Biosolutions Recent Developments/Updates
6.10 Medimmune
6.10.1 Medimmune Corporation Information
6.10.2 Medimmune Description and Business Overview
6.10.3 Medimmune Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Medimmune Measles Vaccine Product Portfolio
6.10.5 Medimmune Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Corporation Information
6.11.2 Johnson & Johnson Measles Vaccine Description and Business Overview
6.11.3 Johnson & Johnson Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Johnson & Johnson Measles Vaccine Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 CSL Limited
6.12.1 CSL Limited Corporation Information
6.12.2 CSL Limited Measles Vaccine Description and Business Overview
6.12.3 CSL Limited Measles Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 CSL Limited Measles Vaccine Product Portfolio
6.12.5 CSL Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Measles Vaccine Industry Chain Analysis
7.2 Measles Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Measles Vaccine Production Mode & Process
7.4 Measles Vaccine Sales and Marketing
7.4.1 Measles Vaccine Sales Channels
7.4.2 Measles Vaccine Distributors
7.5 Measles Vaccine Customers
8 Measles Vaccine Market Dynamics
8.1 Measles Vaccine Industry Trends
8.2 Measles Vaccine Market Drivers
8.3 Measles Vaccine Market Challenges
8.4 Measles Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Measles Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Measles Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Measles Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Measles Vaccine Sales (K MT) of Key Manufacturers (2018-2023)
Table 5. Global Measles Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Measles Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Measles Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Measles Vaccine Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Measles Vaccine, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Measles Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Measles Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Measles Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Measles Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Measles Vaccine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Measles Vaccine Sales by Region (2018-2023) & (K MT)
Table 18. Global Measles Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Measles Vaccine Sales by Region (2024-2034) & (K MT)
Table 20. Global Measles Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global Measles Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Measles Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Measles Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Measles Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America Measles Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Measles Vaccine Sales by Country (2018-2023) & (K MT)
Table 27. North America Measles Vaccine Sales by Country (2024-2034) & (K MT)
Table 28. North America Measles Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Measles Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Measles Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Measles Vaccine Sales by Country (2018-2023) & (K MT)
Table 32. Europe Measles Vaccine Sales by Country (2024-2034) & (K MT)
Table 33. Europe Measles Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Measles Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Measles Vaccine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Measles Vaccine Sales by Region (2018-2023) & (K MT)
Table 37. Asia Pacific Measles Vaccine Sales by Region (2024-2034) & (K MT)
Table 38. Asia Pacific Measles Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Measles Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Measles Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Measles Vaccine Sales by Country (2018-2023) & (K MT)
Table 42. Latin America Measles Vaccine Sales by Country (2024-2034) & (K MT)
Table 43. Latin America Measles Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Measles Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Measles Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Measles Vaccine Sales by Country (2018-2023) & (K MT)
Table 47. Middle East & Africa Measles Vaccine Sales by Country (2024-2034) & (K MT)
Table 48. Middle East & Africa Measles Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Measles Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Measles Vaccine Sales (K MT) by Type (2018-2023)
Table 51. Global Measles Vaccine Sales (K MT) by Type (2024-2034)
Table 52. Global Measles Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Measles Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global Measles Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Measles Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Measles Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Measles Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global Measles Vaccine Price (USD/MT) by Type (2018-2023)
Table 59. Global Measles Vaccine Price (USD/MT) by Type (2024-2034)
Table 60. Global Measles Vaccine Sales (K MT) by Application (2018-2023)
Table 61. Global Measles Vaccine Sales (K MT) by Application (2024-2034)
Table 62. Global Measles Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Measles Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global Measles Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Measles Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Measles Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Measles Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global Measles Vaccine Price (USD/MT) by Application (2018-2023)
Table 69. Global Measles Vaccine Price (USD/MT) by Application (2024-2034)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 73. GSK Measles Vaccine Product
Table 74. GSK Recent Developments/Updates
Table 75. Sanofi-Pasteur Corporation Information
Table 76. Sanofi-Pasteur Description and Business Overview
Table 77. Sanofi-Pasteur Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 78. Sanofi-Pasteur Measles Vaccine Product
Table 79. Sanofi-Pasteur Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 83. Merck Measles Vaccine Product
Table 84. Merck Recent Developments/Updates
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 88. Novartis Measles Vaccine Product
Table 89. Novartis Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 93. Pfizer Measles Vaccine Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Serum Institute of India Corporation Information
Table 96. Serum Institute of India Description and Business Overview
Table 97. Serum Institute of India Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 98. Serum Institute of India Measles Vaccine Product
Table 99. Serum Institute of India Recent Developments/Updates
Table 100. China National Biotech Group Corporation Information
Table 101. China National Biotech Group Description and Business Overview
Table 102. China National Biotech Group Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 103. China National Biotech Group Measles Vaccine Product
Table 104. China National Biotech Group Recent Developments/Updates
Table 105. Bavarian Nordic Corporation Information
Table 106. Bavarian Nordic Description and Business Overview
Table 107. Bavarian Nordic Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 108. Bavarian Nordic Measles Vaccine Product
Table 109. Bavarian Nordic Recent Developments/Updates
Table 110. Emergent Biosolutions Corporation Information
Table 111. Emergent Biosolutions Description and Business Overview
Table 112. Emergent Biosolutions Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 113. Emergent Biosolutions Measles Vaccine Product
Table 114. Emergent Biosolutions Recent Developments/Updates
Table 115. Medimmune Corporation Information
Table 116. Medimmune Description and Business Overview
Table 117. Medimmune Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 118. Medimmune Measles Vaccine Product
Table 119. Medimmune Recent Developments/Updates
Table 120. Johnson & Johnson Corporation Information
Table 121. Johnson & Johnson Description and Business Overview
Table 122. Johnson & Johnson Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 123. Johnson & Johnson Measles Vaccine Product
Table 124. Johnson & Johnson Recent Developments/Updates
Table 125. CSL Limited Corporation Information
Table 126. CSL Limited Description and Business Overview
Table 127. CSL Limited Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 128. CSL Limited Measles Vaccine Product
Table 129. CSL Limited Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Measles Vaccine Distributors List
Table 133. Measles Vaccine Customers List
Table 134. Measles Vaccine Market Trends
Table 135. Measles Vaccine Market Drivers
Table 136. Measles Vaccine Market Challenges
Table 137. Measles Vaccine Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Measles Vaccine
Figure 2. Global Measles Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Measles Vaccine Market Share by Type in 2024 & 2034
Figure 4. Mumps Measles Rubella Vaccine, Live (MMR-II) Product Picture
Figure 5. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Product Picture
Figure 6. Global Measles Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Measles Vaccine Market Share by Application in 2024 & 2034
Figure 8. Children
Figure 9. Adults
Figure 10. Global Measles Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 11. Global Measles Vaccine Market Size (2018-2034) & (US$ Million)
Figure 12. Global Measles Vaccine Sales (2018-2034) & (K MT)
Figure 13. Global Measles Vaccine Average Price (USD/MT) & (2018-2034)
Figure 14. Measles Vaccine Report Years Considered
Figure 15. Measles Vaccine Sales Share by Manufacturers in 2024
Figure 16. Global Measles Vaccine Revenue Share by Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Measles Vaccine Players: Market Share by Revenue in 2024
Figure 18. Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 19. Global Measles Vaccine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 20. North America Measles Vaccine Sales Market Share by Country (2018-2034)
Figure 21. North America Measles Vaccine Revenue Market Share by Country (2018-2034)
Figure 22. U.S. Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 23. Canada Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Europe Measles Vaccine Sales Market Share by Country (2018-2034)
Figure 25. Europe Measles Vaccine Revenue Market Share by Country (2018-2034)
Figure 26. Germany Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. France Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. U.K. Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Italy Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Russia Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Asia Pacific Measles Vaccine Sales Market Share by Region (2018-2034)
Figure 32. Asia Pacific Measles Vaccine Revenue Market Share by Region (2018-2034)
Figure 33. China Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Japan Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. South Korea Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. India Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Australia Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Taiwan Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Indonesia Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Thailand Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Malaysia Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Philippines Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Measles Vaccine Sales Market Share by Country (2018-2034)
Figure 44. Latin America Measles Vaccine Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Measles Vaccine Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Measles Vaccine Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE Measles Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Measles Vaccine by Type (2018-2034)
Figure 54. Global Revenue Market Share of Measles Vaccine by Type (2018-2034)
Figure 55. Global Measles Vaccine Price (USD/MT) by Type (2018-2034)
Figure 56. Global Sales Market Share of Measles Vaccine by Application (2018-2034)
Figure 57. Global Revenue Market Share of Measles Vaccine by Application (2018-2034)
Figure 58. Global Measles Vaccine Price (USD/MT) by Application (2018-2034)
Figure 59. Measles Vaccine Value Chain
Figure 60. Measles Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed